Difficult-to-treat and severe asthma: changing the paradigm (webinar)

Learning outcomes

Upon completion of this module the learner will be able to:

• Identify patients with difficult-to-treat asthma.
• Assess and manage factors that contribute to poor asthma control, including inhaler technique, adherence, comorbidities and triggers.
• Identify patient characteristics for severe, high-risk and uncontrolled asthma who may benefit from timely referral to a specialist.
• Describe the role of biologic therapies in severe asthma and the rationale for their use.
• Describe how a multidisciplinary and systematic approach to patients with difficult-to-treat asthma can improve patient outcomes.

Privacy | Copyright | Terms of use

© 2018 National Prescribing Service Limited. This program is joint-funded by AstraZeneca Pty Ltd and Novartis Pharmaceuticals Australia Pty Ltd and managed by VentureWise, a wholly owned commercial subsidiary of NPS MedicineWise. The content has been designed, developed and delivered by NPS MedicineWise with complete independence and editorial control, based on best practice guidelines.